Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 157

1.

Childhood and adolescent large-cell lymphoma (LCL): a review of the Children's Cancer Group experience.

Cairo MS, Sposto R, Hoover-Regan M, Meadows AT, Anderson JR, Siegel SE, Kadin ME, Kjeldsberg CR, Wilson JF, Perkins SL, Lones MA, Morris E, Finlay JL.

Am J Hematol. 2003 Jan;72(1):53-63. Review.

2.

Burkitt's and Burkitt-like lymphoma in children and adolescents: a review of the Children's Cancer Group experience.

Cairo MS, Sposto R, Perkins SL, Meadows AT, Hoover-Regan ML, Anderson JR, Siegel SE, Lones MA, Tedeschi-Blok N, Kadin ME, Kjeldsberg CR, Wilson JF, Sanger W, Morris E, Krailo MD, Finlay JL.

Br J Haematol. 2003 Feb;120(4):660-70.

PMID:
12588354
3.

Large-cell lymphoma arising in the mediastinum in children and adolescents is associated with an excellent outcome: a Children's Cancer Group report.

Lones MA, Perkins SL, Sposto R, Kadin ME, Kjeldsberg CR, Wilson JF, Cairo MS.

J Clin Oncol. 2000 Nov 15;18(22):3845-53.

PMID:
11078498
4.

Non-Hodgkin's lymphoma arising in bone in children and adolescents is associated with an excellent outcome: a Children's Cancer Group report.

Lones MA, Perkins SL, Sposto R, Tedeschi N, Kadin ME, Kjeldsberg CR, Wilson JF, Zwick DL, Cairo MS.

J Clin Oncol. 2002 May 1;20(9):2293-301.

PMID:
11981000
5.

Improved outcome in children with advanced stage B-cell non-Hodgkin's lymphoma (B-NHL): results of the United Kingdom Children Cancer Study Group (UKCCSG) 9002 protocol.

Atra A, Imeson JD, Hobson R, Gerrard M, Hann IM, Eden OB, Carter RL, Pinkerton CR.

Br J Cancer. 2000 Apr;82(8):1396-402.

6.

Primary mediastinal large B-cell lymphoma with sclerosis in pediatric and adolescent patients: treatment and results from three therapeutic studies of the Berlin-Frankfurt-Münster Group.

Seidemann K, Tiemann M, Lauterbach I, Mann G, Simonitsch I, Stankewitz K, Schrappe M, Zimmermann M, Niemeyer C, Parwaresch R, Riehm H, Reiter A; NHL Berlin-Frankfurt-Münster Group.

J Clin Oncol. 2003 May 1;21(9):1782-9.

PMID:
12721255
7.

Comparison of long-term outcome of children and adolescents with disseminated non-lymphoblastic non-Hodgkin lymphoma treated with COMP or daunomycin-COMP: A report from the Children's Cancer Group.

Sposto R, Meadows AT, Chilcote RR, Steinherz PG, Kjeldsberg C, Kadin ME, Krailo MD, Termuhlen AM, Morse M, Siegel SE.

Med Pediatr Oncol. 2001 Nov;37(5):432-41.

PMID:
11745871
8.
9.

CNS involvement in children with newly diagnosed non-Hodgkin's lymphoma.

Sandlund JT, Murphy SB, Santana VM, Behm F, Jones D, Berard CW, Furman WL, Ribeiro R, Crist WM, Greenwald C, Chen G, Walter A, Pui CH.

J Clin Oncol. 2000 Aug;18(16):3018-24.

PMID:
10944136
10.

Long-term follow-up of short intensive multiagent chemotherapy without high-dose methotrexate ('Orange') in children with advanced non-lymphoblastic non-Hodgkin's lymphoma: a children's cancer group report.

Cairo MS, Krailo MD, Morse M, Hutchinson RJ, Harris RE, Kjeldsberg CR, Kadin ME, Radel E, Steinherz LJ, Morris E, Finlay JL, Meadows AT.

Leukemia. 2002 Apr;16(4):594-600.

11.

Outcome of CNS disease at diagnosis in disseminated small noncleaved-cell lymphoma and B-cell leukemia: a Children's Cancer Group study.

Gururangan S, Sposto R, Cairo MS, Meadows AT, Finlay JL.

J Clin Oncol. 2000 May;18(10):2017-25.

PMID:
10811665
12.
13.

[Prognosis and treatment strategies of primary B-cell and NK/T-cell nasopharyngeal non-Hodgkin's lymphoma at early stage].

Zou GR, Zhang YJ, Xie FY, Zheng W, Li HX, Xia YF, Lin TY, Lu TX.

Ai Zheng. 2006 Dec;25(12):1543-9. Chinese.

PMID:
17166383
14.

[Progress in the treatment of non-Hodgkin's lymphoma (NHL) in children. The report of Polish Pediatric Leukaemia/lymphoma Study Group (PPLLSG)].

Wróbel G, Kazanowska B, Chybicka A, Jeleń M, Małdyk J, Sowińska E, Balcerska A, Balwierz W, Bubała H, Kołakowska-Mrozowska B, Kołtan A, Korzon M, Kowalczyk J, Krawczuk-Rybak M, Maciejka-Kapuścińska L, Matysiak M, Płoszyńska A, Popadiuk S, Solarz E, Sońta-Jakimczyk D, Sopyło B, Stańczak E, Stefaniak J, Stefańska K, Wachowiak J, Wieczorek M, Wysocki M.

Przegl Lek. 2004;61 Suppl 2:45-8. Polish.

PMID:
15686045
15.

Discordant bone marrow involvement in diffuse large-cell lymphoma: a distinct clinical-pathologic entity associated with a continuous risk of relapse.

Robertson LE, Redman JR, Butler JJ, Osborne BM, Velasquez WS, McLaughlin P, Swan F, Rodriguez MA, Hagemeister FB, Fuller LM, et al.

J Clin Oncol. 1991 Feb;9(2):236-42.

PMID:
1988571
16.

Favorable prognosis for patients 12 to 18 months of age with stage 4 nonamplified MYCN neuroblastoma: a Children's Cancer Group Study.

Schmidt ML, Lal A, Seeger RC, Maris JM, Shimada H, O'Leary M, Gerbing RB, Matthay KK.

J Clin Oncol. 2005 Sep 20;23(27):6474-80. Epub 2005 Aug 22.

17.
18.

Clinical characteristics and treatment results of pediatric B-cell non-Hodgkin lymphoma patients in a single center.

Karadeniz C, Oguz A, Citak EC, Uluoglu O, Okur V, Demirci S, Okur A, Aksakal N.

Pediatr Hematol Oncol. 2007 Sep;24(6):417-30.

PMID:
17710659
19.

Intensive chemotherapy without radiotherapy gives more than 85% event-free survival for non-Hodgkin lymphoma without central nervous involvement: a 6-year population-based study from the nordic society of pediatric hematology and oncology.

Márky I, Björk O, Forestier E, Jónsson OG, Perkkiö M, Schmiegelow K, Storm-Mathiesen I, Gustafsson G; Nordic Society of Pediatric Hematology and Oncology.

J Pediatr Hematol Oncol. 2004 Sep;26(9):555-60.

PMID:
15342981
20.

Factors contributing to the prognostic significance of bone marrow involvement in childhood non-Hodgkin lymphoma.

Sandlund JT, Ribeiro R, Lin JS, Ayers D, Santana VM, Furman WL, Mahmoud H, Berard CW, Hutchison RE, Crist WM, et al.

Med Pediatr Oncol. 1994;23(4):350-3.

PMID:
8058006
Items per page

Supplemental Content

Write to the Help Desk